| Product NDC: | 51672-1340 |
| Proprietary Name: | Betamethasone Dipropionate |
| Non Proprietary Name: | Betamethasone Dipropionate |
| Active Ingredient(s): | .5 mg/mL & nbsp; Betamethasone Dipropionate |
| Administration Route(s): | TOPICAL |
| Dosage Form(s): | LOTION, AUGMENTED |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 51672-1340 |
| Labeler Name: | Taro Pharmaceuticals U.S.A., Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA077477 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070521 |
| Package NDC: | 51672-1340-4 |
| Package Description: | 60 mL in 1 BOTTLE (51672-1340-4) |
| NDC Code | 51672-1340-4 |
| Proprietary Name | Betamethasone Dipropionate |
| Package Description | 60 mL in 1 BOTTLE (51672-1340-4) |
| Product NDC | 51672-1340 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Betamethasone Dipropionate |
| Dosage Form Name | LOTION, AUGMENTED |
| Route Name | TOPICAL |
| Start Marketing Date | 20070521 |
| Marketing Category Name | ANDA |
| Labeler Name | Taro Pharmaceuticals U.S.A., Inc. |
| Substance Name | BETAMETHASONE DIPROPIONATE |
| Strength Number | .5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |